Adamas Pharmaceuticals Inc. buy Quitte
Start price
23.12.15
/
50%
€20.62
Target price
06.01.16
€23.36
Performance (%)
12.12%
End price
06.01.16
€23.12
Summary
This prediction ended on 06.01.16 with a price of €23.12. The BUY prediction by Quitte finished with a performance of 12.12%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.232% | 1.501% | 11.288% | 63.495% |
| iShares Nasdaq 100 | 0.695% | -1.949% | 5.586% | 88.830% |
| iShares Nikkei 225® | 2.085% | 11.061% | 31.150% | 67.951% |
| iShares S&P 500 | 0.419% | 0.215% | 4.116% | 60.991% |
Comments by Quitte for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
Erfolge bei Parkinson
Adamas Pharma: Phase-3-Studie zu ADS-5102 erzielt gewünschte Resultate
(Stop Loss Kurs erreicht)

